Erika has a Ph.D. in biological engineering and is particularly well-suited to advise patent prosecution clients in the biotech field. Her areas of technical expertise include high throughput screening, CRIPSR, DNA damage cell signaling, and cancer biology.
Erika joined Klarquist in 2023 as a part-time technical consultant and became a patent agent in 2024.